Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease
Authors:
- Gjin NdrepepaGNGjin Ndrepepa
- Werner KochWKWerner Koch
- Siegmund BraunSBSiegmund Braun
- Julinda MehilliJMJulinda Mehilli
- Albert SchömigASAlbert Schömig
- Adnan KastratiAKAdnan Kastrati
- 1 May 2004
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (10) , 1201-1206
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- MTHFR 677C→T Polymorphism and Risk of Coronary Heart DiseaseJAMA, 2002
- The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineAtherosclerosis, 2001
- Determinants of plasma total homocysteine concentration in the Framingham Offspring cohortThe American Journal of Clinical Nutrition, 2001
- Blood Levels of Homocysteine and Increased Risks of Cardiovascular DiseaseArchives of internal medicine (1960), 2000
- Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): Population Reference Ranges and Contribution of Vitamin Status to High Serum ConcentrationsAnnals of Internal Medicine, 1999
- Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic EvidenceAnnals of Internal Medicine, 1999
- Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular DiseaseCirculation, 1998
- Hyperhomocysteinemia and Thrombosis: Acquired ConditionsThrombosis and Haemostasis, 1997
- Total Plasma Homocysteine and Cardiovascular Risk ProfileJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995